• Tricine-SDS-PAGE Electrophoresis System Guide

  2026-09-13

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit is designed to improve separation of small proteins and peptides that are difficult to resolve with conventional Tris-SDS-PAGE. It is intended for research protein electrophoresis, including denaturing and non-denaturing workflows, and must not be used for diagnostic, clinical, or medical testing.

• ABT-263 (Navitoclax): Apoptosis Research Guide

  2026-09-12

  ABT-263, also called Navitoclax, is an orally bioavailable Bcl-2 family inhibitor for mechanistic cancer biology and apoptosis assay workflows. Its strongest research value is the high-affinity disruption of Bcl-2, Bcl-xL, and Bcl-w interactions, with interpretation limited by context-dependent dependence on MCL1 and mitochondrial priming.

• 2-Hydroxypropyl-β-cyclodextrin Workflow Guide

  2026-09-12

  2-Hydroxypropyl-β-cyclodextrin is a water-soluble cyclic oligosaccharide for improving the apparent aqueous solubility of poorly soluble hydrophobic compounds, particularly molecules with aromatic or phenyl groups. It is suitable for pharmaceutical solubility improvement, drug formulation excipient screening, and biochemical formulation workflows, but the available dossier does not establish therapeutic efficacy, safety, pharmacokinetic benefit, or bioavailability.

• Perphenazine: D2 Antagonist Research Guide

  2026-09-11

  Perphenazine is a dopamine D2 receptor antagonist with a broader phenothiazine receptor binding profile. Research data support its use as a benchmark compound for receptor pharmacology, mitochondria-mediated cell death induction, opioid tolerance suppression, and emerging host-directed antibacterial studies.

• Partial Aβ Reduction and Synaptic Transmission

  2026-09-11

  Satir et al. used optical electrophysiology with primary cortical neurons to test whether moderate BACE inhibition can lower amyloid beta secretion without impairing synaptic transmission. Their results support partial, rather than extensive, enzyme inhibition as a potentially safer strategy for preventive Alzheimer’s disease research, while emphasizing that stronger inhibition may disrupt neuronal function.

• SP1–ADAM10–DRP1 Axis in Hypoxic Pulmonary Hypertension

  2026-09-10

  This 2025 study identifies an SP1/ADAM10/DRP1 signaling framework that connects hypoxia-activated endothelial cells with pulmonary artery smooth muscle cells in hypoxia pulmonary hypertension. Its conditioned-medium and inhibitor experiments suggest that endothelial ADAM10 promotes smooth muscle proliferation and survival through DRP1 and PI3K/AKT/mTOR signaling, providing a mechanistic basis for studying intercellular vascular remodeling.

• ABT-737: BCL-2 Protein Inhibitor Guide

  2026-09-10

  ABT-737 is a BH3 mimetic BCL-2 protein inhibitor that targets BCL-2, BCL-xL, and BCL-w to promote intrinsic mitochondrial apoptosis. Preclinical evidence supports apoptosis induction in cancer cells, including lymphoma, multiple myeloma, small-cell lung cancer, and acute myeloid leukemia models.

• DNase I (RNase-free) for Causal CRC Assays

  2026-09-09

  Learn how DNase I (RNase-free) strengthens RNA, RT-PCR, transcription, and chromatin workflows used to investigate CAF-driven oxaliplatin resistance. This guide connects nuclease chemistry with contamination-aware causal inference in colorectal cancer research.

• OPP Protein Synthesis Assay: Workflow & Tips

  2026-09-09

  O-propargyl-puromycin (OPP) enables rapid, nonradioactive measurement of nascent protein production in cells, with applications ranging from activated B-cell biology to translational stress profiling. This guide connects OPP labeling, click-chemistry detection, quantitative analysis, and troubleshooting to the mitochondrial mechanism described in a recent B-cell study.

• Mianserin HCl: Applied 5-HT2 Assay Workflows

  2026-09-08

  Mianserin HCl combines 5-HT2 receptor antagonism with a practical profile for serotonergic signaling, psychiatric disorder, and inclusion-complex studies. This guide translates clinical pharmacology findings into bench workflows, concentration choices, controls, and troubleshooting strategies for reproducible research.

• SB203580 Workflows for p38 MAPK Research

  2026-09-07

  Use SB203580 as a reversible, ATP-competitive probe to connect p38 MAPK activity with epithelial inflammation, neutrophil chemotaxis, and tissue-injury readouts. This workflow translates a periodontitis–COPD mechanism into practical cell-based assays while highlighting dose, timing, solubility, and off-target controls.

• Sulfo-NHS-Biotin for Phage Assay Workflows

  2026-09-07

  Sulfo-NHS-Biotin adds covalent, aqueous-compatible labeling to workflows that investigate bacterial surfaces, phage binding, and protein capture. Combined thoughtfully with phage-layer interferometry, it can provide orthogonal biochemical context without confusing receptor labeling with proof of infectivity.

• Freeze-Driven Betaine Loading Improves mRNA Delivery

  2026-09-05

  The reference study shows that freezing can do more than preserve lipid nanoparticles: freeze concentration drives betaine into the particles, where it improves endosomal escape and mRNA delivery. This formulation concept increased reporter expression and strengthened immune responses in female mice, while also suggesting a route toward dose-sparing mRNA systems.

• Biotin-16-UTP: From RNA Mechanism to Translation

  2026-09-04

  A thought-leadership guide to using Biotin-16-UTP as an affinity-enabled RNA labeling strategy for mechanistic studies of lncRNA biology, including the LINC02870–EIF4G1–SNAIL axis in hepatocellular carcinoma. The article connects assay design, validation, translational relevance, and practical limitations.

• A-1210477: Translating MCL-1 Dependence

  2026-09-04

  MCL-1 inhibitor A-1210477 offers a focused way to interrogate BIM sequestration, mitochondrial apoptosis, and cancer cell survival regulation in MCL-1-dependent models. This thought-leadership guide connects mechanistic biology with assay design, combination strategy, and translational decision-making while clearly defining the compound’s in vivo limitations.

8044 records 1/537 page Next 12345 下5页 Last page